Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
CORONAVIRUS DISEASE 2019 (COVID-19) IN THE HEART TRANSPLANT POPULATION: A SINGLE-CENTER EXPERIENCE
Session:
Posters - E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Speaker:
M. Raquel Santos
Congress:
CPC 2021
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
14. Acute Cardiac Care
Subtheme:
14.6 Acute Cardiac Care – Other
Session Type:
Posters
FP Number:
---
Authors:
M. Raquel Santos; Bruno Rocha; Catarina Brízido; Gonçalo Cunha; Sérgio Maltês; Christopher Strong; António Tralhão; Carlos Aguiar; Miguel Mendes
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">BACKGROUD: The worldwide spread of the novel coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges in the diagnosis and medical treatment of affected patients as well as in public health management. Data on the clinical course of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in heart transplant recipients are scarce. Immunosuppression-related issues present the main concern in this special population.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">PURPOSE: To describe our experience with transplanted patients who developed this disease.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">METHODS: Six patients developed the novel 2019 coronavirus disease. Data on demographic features, last follow-up characteristics, immunosuppressive therapy, onset presentation and need for hospitalization were collected for these patients.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">RESULTS: The median age was 48.8 years (IQR 30-40) and 50% of the patients were male. Among the patients’ risk factors arterial hypertension and past smoking were the most frequent, occurring in 50%. The median glomerular filtration rate was 68 ml/min/1.73m<sup>2</sup> (IQR 45–114). Five patients were on a triple immunosuppressive therapy regimen. All patients were symptomatic and had positive results from a nasopharyngeal swab test for SARS-CoV-2. Just one presented fever. Of the six patients, only two required hospitalization: one patient was admitted to an intensive care unit for 86 days and the other to a general ward for 35 days. The former patient developed severe pneumonia and respiratory failure requiring invasive mechanical ventilation, acute renal failure requiring hemodialysis, and was discharged to a rehabilitation unit. During hospitalization, immunosuppressive therapy was modified and down-titrated in both patients. At the last follow-up, all patients are alive and have preserved graft function. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">CONCLUSIONS: In this small cohort of heart transplant recipients infected by SARS-CoV-2, a third required hospitalization, but all survived. Immunosuppression was down-titrated in patients requiring hospitalization. </span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site